Agenus to Report First Quarter 2013 Financial Results on April 24, 2013; Conference Call to Follow
April 18, 2013 07:00 ET
|
Agenus Inc.
LEXINGTON, Mass., April 18, 2013 (GLOBE NEWSWIRE) -- Agenus Inc. (Nasdaq:AGEN) will release its first quarter 2013 financial results before the market opens on April 24, 2013.
Agenus executives will...
Agenus Eliminates Its $39 Million Senior Notes and Completes $10 Million of New Debt Financing
April 16, 2013 07:00 ET
|
Agenus Inc.
LEXINGTON, Mass., April 16, 2013 (GLOBE NEWSWIRE) -- Agenus Inc. (Nasdaq:AGEN), a leading developer of therapeutic vaccines for cancer and infectious diseases, reported today that it has retired its...
Agenus' Brain Cancer Vaccine Results to be Presented at Plenary Session of the 81st American Association of Neurological Surgeons (AANS) Annual Scientific Meeting
April 10, 2013 07:00 ET
|
Agenus Inc.
LEXINGTON, Mass., April 10, 2013 (GLOBE NEWSWIRE) -- Agenus Inc. (Nasdaq:AGEN) reported today that Orin Bloch, MD, Clinical Instructor, Department of Neurological Surgery, University of California San...
Agenus to Present at the ROTH Annual Conference
March 14, 2013 14:00 ET
|
Agenus Inc.
LEXINGTON, Mass., March 14, 2013 (GLOBE NEWSWIRE) -- Agenus Inc. (Nasdaq:AGEN), a developer of therapeutic vaccines for cancer and infectious diseases, today announced that the company will be...
Agenus Reports Fourth Quarter and Year End 2012 Financial Results
February 28, 2013 07:00 ET
|
Agenus Inc.
LEXINGTON, Mass., Feb. 28, 2013 (GLOBE NEWSWIRE) -- Agenus Inc. (Nasdaq:AGEN), a biotechnology company working to develop novel immunology based treatments for cancers and infectious diseases, today...
Agenus' HerpV Phase 2 Study to Treat Genital Herpes Completes Enrollment
February 27, 2013 07:00 ET
|
Agenus Inc.
HerpV is clinically the most advanced therapeutic vaccine for the treatment of genital herpes
HerpV contains Agenus' QS-21 Stimulon®* adjuvant currently being studied in 17 other...
Agenus to Present at Cowen and Company Annual Healthcare Conference
February 26, 2013 09:00 ET
|
Agenus Inc.
LEXINGTON, Mass., Feb. 26, 2013 (GLOBE NEWSWIRE) -- Agenus Inc. (Nasdaq:AGEN), a developer of therapeutic vaccines for cancer and infectious diseases, today announced that the company will be...
Agenus to Report Fourth Quarter and Year End 2012 Financial Results on February 28, 2013; Conference Call to Follow
February 21, 2013 07:00 ET
|
Agenus Inc.
LEXINGTON, Mass., Feb. 21, 2013 (GLOBE NEWSWIRE) -- Agenus Inc. (Nasdaq:AGEN) will release its fourth quarter and year ended December 31, 2012 financial results before the market opens on February 28,...
Agenus to Present at BIO CEO & Investor Conference
February 06, 2013 08:15 ET
|
Agenus Inc.
LEXINGTON, Mass., Feb. 6, 2013 (GLOBE NEWSWIRE) -- Agenus Inc. (Nasdaq:AGEN), a developer of therapeutic vaccines for cancer and infectious diseases, today announced that the company will be...
Agenus to Present at OneMedForum San Francisco 2013
January 02, 2013 15:53 ET
|
Agenus Inc.
LEXINGTON, Mass., Jan. 2, 2013 (GLOBE NEWSWIRE) -- Agenus Inc. (Nasdaq:AGEN), a developer of therapeutic vaccines for cancer and infectious diseases, today announced that the company will be...